Status:

UNKNOWN

Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Kidney Transplantation

Liver Transplantation

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Kidney and liver transplantation requires a fine tuning of immune responses in order to achieve long term operational tolerance with immunosuppressants or immune modulators. Numerous experimental find...

Eligibility Criteria

Inclusion

  • For liver transplant patients:
  • Liver transplantation carried out for 1 to 3 months for alcoholic cirrhosis;
  • Normal liver biological test;
  • Normal hepatic morphological assessment;
  • For kidney transplant patients:
  • Renal transplantation carried out for 3 to 6 months for any disease requiring renal transplantation;
  • Normal renal biological assessment;
  • Normal renal morphological assessment;
  • DSA \<1500 MFI at inclusion
  • Common criteria:
  • Age ≥ 18 years and ≤ 70 years
  • GB ≥1500 / mm3
  • Hemoglobin level\> 10g / 100ml
  • Platelets\> 50,000 / μl
  • Weight\> 40Kg
  • Informed and signed consent;
  • Patient affiliated to a social security scheme

Exclusion

  • For liver transplant patients:
  • \- Hepatocellular carcinoma or history of another cancer;
  • For kidney transplant patients:
  • \- Kidney cancer or a history of another cancer
  • Common criteria:
  • Active infectious diseases: positive serology for hepatitis A, B or C, HIV, HTLV, CMV and EBV;
  • Associated autoimmune disease, including type 1 diabetes;
  • GB \<1500 / mm3;
  • Any contraindication to citrate and calcium gluconate.
  • Pregnancy or lactating woman
  • Patient under guardianship or curatorship
  • Patient deprived of liberty or under administrative security measure

Key Trial Info

Start Date :

April 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 30 2024

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT04661254

Start Date

April 15 2023

End Date

April 30 2024

Last Update

March 28 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Pitié Salpêtrière hospital

Paris, France, 75013

2

Pitié Salpêtrière hospital

Paris, France, 75013